Email ID
Password
Forgotten your password?
Advanced Search
Home
Companies
Patients
Investigators
Trials & Research
Regulatory
Therapeutics
Patients
LATEST NEWS
Acurian applauds social networking for recruitment and referral
05 March 2010
Patient recruitment specialist Acurian has revealed that over 50% of patient referrals in 2009 were generated from online sources, including large health networks and social media platforms like Facebook and MySpace. Acurian has established proprietary relationships with international health ...
US trial professionals positive about the future of cancer r...
Synexus recruits high numbers in South African paediatrics t...
Praxis awarded recruitment contract for Diabetes trial
02 March 2010
Centralised patient recruitment company Praxis will provide patient recruitment services to a top 20 pharmaceutical company for an international study on type 2 diabetes. The study explores an investigational drug's effectiveness for maintaining glycemic control for individuals newly diagnosed ...
Poland and South Africa outperform rest of the market in Synexus recruitment drive
01 March 2010
Patient recruitment specialist Synexus has recruited 87% of patients for an osteoporosis study for a major biotech, recruiting 494 of the total 565 patients at international sites. The trial involved eleven of Synexus' twenty six recruitment centres across the UK, Europe and South Africa. There ...
Patient recruitment site launched
22 February 2010
A search and referral site for clinical studies, TrialReach, has launched covering more than 25,000 open studies, for all medical conditions, anywhere in the world. The search engine combines proprietary search technology, new and exclusive content, and communication channels between patients and ...
>> More Latest News...
FEATURES
Location, Location, Location
09 October 2009
Geography, and local knowledge there of, can be a huge factor when recruiting patients for clinical trials. Gerard Dunne of New Zealand-based CRO BELTAS raises important recruitment considerations for those planning on conducting trials downunder. Patient recruitment consumes more time than any ...
Making a case for the Middle East...
GPP versus GCP: design, conduct, implementation and interpre...
EndPoint: Christine Pierre
09 October 2009
Christine Pierre founded her company, RxTrials, in 2004. She is the past chair of ACRP, and editorial board member of Clinical Trials Advisor and eCliniqu, a member of the steering committee of the Clinical Trials Transformation Initiative. She co-authored the book Responsible Research: A ...
>> More Features...
PEOPLE
ACM appoints Asia Pacific manager
ACM Global Central Laboratory has appointed a new general manager of Asia Pacific, Nandan Rao , who will spearhead the company's growth in India and Southeast Asia. His first responsibility will be to oversee trials conducted by ACM's partner laboratory, before building the company’s own local ...
Venn Life Sciences hires new VP of business development
Venn Life Sciences has hired Dale Trask as vice-president of global business development. Mr Trask brings extensive experience in CRO business development and will be responsible for enhancing Venn's business partnerships, strategic relationships and growth into new markets. Mr Trask joins Venn ...
Entest Biomedical adds CRO experience to scientific board
Entest BioMedical has appointed Dr Vladimir Bogin to its scientific advisory board (SAB). Dr Bogin is the CEO of CRO Cromos Pharma. The company feels the addition of Dr Bogin to the SAB will "greatly assist in developing its clinical protocols as it moves forward to conducting both preclinical and ...
>> More People...
COMMENTARY
Renal Failure: challenges and opportunities
The term renal failure describes a decline in the excretory function of the kidney due to a reduction in glomerular filtration rate. In adults, renal failure may be either acute, lasting from a few days to a few weeks, or chronic, lasting months to years. Acute renal failure is a medical ...
Filling the gaps
Most stakeholders in Europe are in favour of some form of EU centralised approval system for multinational clinical trials, with the pharmaceutical industry and the European Medicines Agency among the strongest backers for such a move. But the support is not unanimous: many national regulatory ...
The fight against malaria - all still to play for
If you didn't know, how many cases of malaria would you guess occur every year around the globe? A million? Two million? In fact, around 250 million cases of malaria occur each year. Most of these occur in developing countries, although malaria is also an issue for travellers from developed ...
UK wants harmonisation, not centralisation, of European trial approvals
The UK drug regulator, the MHRA, says it does not want a centralised approvals system for clinical trials in Europe, preferring instead the voluntary harmonisation project for authorising multinational studies that is currently being piloted in the EU. The MHRA also feels that introducing a single ...
EU promises multinational CTA harmonisation at last
The problem stems mainly from the way that the EU clinical trials Directive (2001/20/EC) has been implemented by the various member states. National authorities have different format, language and content requirements for clinical trial approvals, as well as different timelines for reviewing ...
Search continues for improved BPH treatments
The recent announcement by Boehringer Ingelheim that it plans to make the alpha blocker tamsulosin available without a prescription in the UK is a reflection of the continued interest in the benign prostatic hyperplasia (BPH) market. The condition affects some 15 million men across the seven major ...
>> More Commentary...
About Us
Getting Started
Subscribe
FREE Trial
Advertise
Awards
White Papers
EVENTS
Designing the Future Conditions for Clinical Research in Europe
17 March 2010
Brussels, Belgium
ICR Annual Spring Conference and Exhibition
19 April 2010
London, UK
CDISC Interchange Europe
26 April 2010
London, UK
